Epidemiologie - France Portal | Health Databases

Home

Catalogue

Catalogue
ARCHIVES

Covid-19

Resources

Lexicon
Legal notices

Useful links

General links
Covid-19 links

Login in to your account

Email address Password

You do not have an account yet ? Sign up !

You have forgotten your password ?

Portail Epidémiologique

ITMO public health Aviesan

Aviesan

Archives

Search with one or more keywords

All records French records only English records only

This page gives you access to all the studies carried out by French researchers, identified on Covid-19.

To view other resources related to Covid-19, click here.

xml

Export to XML

Please choose the format :

pdf

Export to PDF

Which version do you want to export ?

Download full content

Download light content

csv

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

ARCHIVES : 309 forms

Sorting of results :

HEPATYS - Cohort study on management and outcome of patients with chronic Hepatitis C treated with PEG-IFN-alpha2a in combinaison with ribavirin in hospital-based or private office-based

Head : Pinta Alexandrina, ROCHE

Version 2

79

Last update : 09/05/2017

ARCHIVE

HEPATYS - Cohort study on management and outcome of patients with chronic Hepatitis C treated with PEG-IFN-alpha2a in combinaison with ribavirin in hospital-based or private office-based

Head : Pinta Alexandrina, ROCHE

Main objective

Describe the management and outcome of patients with chronic Hepatitis C treated with PEG-IFN-alpha2a in combinaison with ribavirin in hospital-based or private office-based

Inclusion criteria

Patients suffering from chronic hepatitis C for whom a treatment via Pagasys was decided and then initiated, followed in a hospital and general environment
Patients who have been informed of the study orally and in writing

Last update : 09/05/2017

EMU - Cross-sectional Study on Migraine Patients in Emergency Service Departments: Diagnosis and Treatment

Head : Grun-Overdyking Aurélie, Pfizer

Version 1

80

Last update : 01/01/2018

ARCHIVE

EMU - Cross-sectional Study on Migraine Patients in Emergency Service Departments: Diagnosis and Treatment

Head : Grun-Overdyking Aurélie, Pfizer

Main objective

Primary:
- To estimate the frequency of patients admitted with headaches and to estimate the frequency of patients diagnosed with migraine.
- To characterise patients diagnosed with migraines attending emergency services based on demographic data and migraine history (age, severity).
- To describe the treatment of patients diagnosed with a migraine during emergency service consultation.
Secondary:
- To describe the treatment of patients diagnosed with a migraine according to the type of migraine.
- To describe the frequency of patients diagnosed with a migraine and their treatment by emergency structure type.
- To describe treatment follow-up.

Inclusion criteria

- Patients aged 18 or older.
- Patients deemed capable of answering the questions.
- Patients agreeing to participate in the survey.
- Patients admitted to emergency department

Last update : 01/01/2018

MENUI - Cohort of children with isolated nocturnal enuresis : a study of the safety of Minirinmelt in actual prescription

Head : Niez Philippe, Laboratoire FERRING S.A.S

Version 1

81

Last update : 01/01/2020

ARCHIVE

MENUI - Cohort of children with isolated nocturnal enuresis : a study of the safety of Minirinmelt in actual prescription

Head : Niez Philippe, Laboratoire FERRING S.A.S

Main objective

Show that the two oral forms (tablet and lyophilisate) of desmopressin have a similar safety profile and in particular in terms of frequency of the symptoms of alarms of an intoxication via water, in actual prescription situations, i.e. at general practitioners.

Inclusion criteria

Criteria for inclusion:
-patient having an isolated nocturnal enuresis, defined by the number of wet nights per week,
-patient aged 6 to 18 years,
-patient in which the family doctor has decided to prescribe a treatment via desmopressin, or Minirin® tablets or Minirinmelt® lyophilisate.

Criteria for non-inclusion:
-patient who has already received prior treatment via desmopressin regardless of its form,
-patient who has a treatment in progress via desmopressin,
-patient participating in a therapeutic study.

Last update : 01/01/2020

B009 - Follow-up study of patients treated with drotrecogin alfa (activated) (Xigris®) in France

Head : Laboratoire , Eli Lilly France

Version 1

82

Last update : 01/01/2019

ARCHIVE

B009 - Follow-up study of patients treated with drotrecogin alfa (activated) (Xigris®) in France

Head : Laboratoire , Eli Lilly France

Main objective

Primary objective: evaluate 1-month mortality (at 28 days and 31 days) of patients treated with drotrecogin alpha (activated) in intensive care forsevere sepsis and describe causes of death.
Secondary objectives: characteristics of patients and conditions of use.

Inclusion criteria

All adult patients treated with drotrecogin alpha (activated) in France in the course of routine care in intensive care services.

Last update : 01/01/2019

- Prevalence of gastroesophageal reflux disease (GERD) during childhood in France

Head : Piedbois Pascal
Thomas-Delecourt Florence, AstraZeneca

Version 3

83

Last update : 01/01/2018

ARCHIVE

- Prevalence of gastroesophageal reflux disease (GERD) during childhood in France

Head : Piedbois Pascal
Thomas-Delecourt Florence, AstraZeneca

Main objective

To assess prevalence of gastroesophageal reflux during childhood and teenage years in France

Inclusion criteria

Children / teenagers from 0 to 17 years of age

Last update : 01/01/2018

- Managing Fever in Children: A National Survey of Parents' Knowledge and Practices in France

Head : Chalumeau Martin, U953 Recherche épidémiologique en santé périnatale et santé des femmes et des enfantsÉquipe/activité : Epidémiologie clinique et organisation des soins

Version 2

84

Last update : 06/01/2018

ARCHIVE

- Managing Fever in Children: A National Survey of Parents' Knowledge and Practices in France

Head : Chalumeau Martin, U953 Recherche épidémiologique en santé périnatale et santé des femmes et des enfantsÉquipe/activité : Epidémiologie clinique et organisation des soins

Main objective

Study parents' knowledge and practices and their determinants in managing fever symptoms in children in France as compared with current recommendations.

Inclusion criteria

man or woman - children between 1 month and 12 years old - having fever since less than 48h

Last update : 06/01/2018

Previous
1
...
8
9
10
11
12
13
14
15
16
17
18
19
20
...
52
Next

Please wait...

ABOUT

Help about your workspace

CATALOG

RESOURCES

USEFUL LINKS

This site complies with the HONcode standard for trustworthy health information:
verify here.

8 rue de la Croix Jarry

75013 Paris

Phone : +33 1 44 23 67 47

portail-epidemiologie@inserm.fr

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

XXX

View Edit Create here